Days later, a City University of New York scientist behind a well-financed, controversial Alzheimer’s drug was indicted on ...
Experts say they're "cautiously enthusiastic about the fact that we're probably heading in the right direction" as nasal ...
Wang is accused of fabricating several aspects of his research on a drug treatment for Alzheimer’s disease when applying for ...
Researchers have found unique molecular changes in the blood-brain barrier of people with Alzheimer’s disease, markers of ...
GSK reached a licensing agreement with mRNA-vaccine developer CureVac worth up to $1.8 billion to develop its vaccines for ...
The Chicago Tribune reports that a new system to help fair distribution of donor lungs was built on a flawed algorithm which harmed some sick and dying patients. Meanwhile a researcher was indicted on ...
A neuroscientist whose work helped pave the way for an Alzheimer’s drug candidate was indicted by a federal grand jury on ...
In May 2023, drugmaker Lilly announced that its new Alzheimer’s drug, donanemab ... Medeiros With AI Tools, Scientists Can Crack the Code of Life Google’s AI research lab DeepMind is steadily ...
Scientists in Japan say they have reversed the signs of Alzheimer’s disease in lab mice ... with mice to clinical trials and then finally into a drug that's commercially available can take ...
Scientists in Japan say they have reversed the signs of Alzheimer’s disease in lab mice by restoring the ... Going from experiments with mice to clinical trials and then finally into a drug that's ...
But research scientists and ... they were likely to develop Alzheimer’s and 64% said they would be likely to experience significant distress. Because the science behind blood tests for Alzheimer ...